David Bredt Rapport Therapeutics, Inc. (RAPP) insider trading activity

RAPP Quotes by TradingView
Shares Held (Direct Ownership) 469K
n/a 3M change
n/a 12M change
Total Value Held N/A

David Bredt Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 14 2025
SELL
Open market or private sale
$92,225 $10.85 p/Share
8,500 Reduced 1.78%
469,142 Common Stock
DB

David Bredt

Chief Scientific Officer
Boston, MA

Track Institutional and Insider Activities on RAPP

Follow Rapport Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RAPP shares.

Notify only if

Insider Trading

Get notified when an Rapport Therapeutics, Inc. insider buys or sells RAPP shares.

Notify only if

News

Receive news related to Rapport Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RAPP